查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1387489

ELISA（酵素结合免疫吸附检测法）市场报告：2030 年趋势、预测与竞争分析

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

ELISA（酵素结合免疫吸附检测法）的趋势和预测

预计 2024 年至 2030 年，全球 ELISA 方法市场将以 7.5%的年复合成长率成长。该市场的主要驱动因素是爱滋病毒、登革热、肝炎、疟疾、流感等感染疾病的流行以及面临多种感染疾病风险的老年人口的增加。全球 ELISA 市场的未来前景广阔，为医院和诊断中心、製药和生物技术公司、学术研究中心和临床实验室市场提供了商机。

ELISA 市场洞察

Lucintel 预测，由于便携性和持续的技术进步，多重/便携式 ELISA 将在预测期内实现最高成长。

在这个市场中，由于疾病盛行率不断上升、对个人化医疗的需求不断增长以及政府对 ELISA 方法的支持不断增加，医院和诊断中心仍将是最大的细分市场。

由于老年人口迅速增长、医疗设备普及不断提高以及先进的医疗基础设施的存在，北美在预测期内可能仍然是最大的地区。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球 ELISA 市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球 ELISA 市场趋势（2018-2023）与预测（2024-2030）
  • 按类型分類的全球 ELISA 方法市场
    • 夹心ELISA
    • 间接ELISA
    • 多重/便携式 ELISA
    • 竞争ELISA
  • 按应用分類的全球 ELISA 市场
    • 免疫
    • 疫苗开发
    • 感染疾病
    • 癌症
    • 蛋白质定量
    • 其他的
  • 按最终用途分類的全球 ELISA 方法市场
    • 医院/诊断中心
    • 製药和生物技术公司
    • 学术研究中心
    • 临床实验室
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球 ELISA 方法市场（按地区）
  • 北美ELISA市场
  • 欧洲ELISA市场
  • 亚太 ELISA 市场
  • 其他地区ELISA市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按类型分類的全球 ELISA 方法市场成长机会
    • 按应用分類的全球 ELISA 市场成长机会
    • 按最终用途分類的全球 ELISA 方法市场成长机会
    • 按地区分類的全球 ELISA 方法市场成长机会
  • 全球 ELISA 市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球 ELISA 市场的产能
    • 全球ELISA市场的合併、收购和合资企业
    • 认证和许可

第7章主要企业概况

  • Ortho Clinical Diagnostics
  • Thermo Fisher Scientific
  • BioMerieux
  • Sysmex Corporation
  • F. Hoffmann-La Roche
  • Danaher Corporation
  • Quidel Corporation
  • Bio-Rad Laboratories
  • Siemens Healthineers
  • Abbott Laboratories
简介目录

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Trends and Forecast

The future of the global enzyme-linked immunosorbent assay (ELISA) tests market looks promising with opportunities in the hospital and diagnostic center, pharmaceutical and biotech company, academic research center, and clinical laboratory markets. The global enzyme-linked immunosorbent assay (ELISA) tests market is expected to grow with a CAGR of 7.5% from 2024 to 2030. The major drivers for this market are growing prevalance of infectious diseases, such as HIV, dengue, hepatitis, malaria, influenza, and others and growing geriatric population who are at a risk of developing several infections.

A more than 150-page report is developed to help in your business decisions.

Enzyme-Linked Immunosorbent Assay (ELISA) Tests by Segment

The study includes a forecast for the global enzyme-linked immunosorbent assay (ELISA) tests by type, application, end use, and region.

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Sandwich ELISA
  • Indirect ELISA
  • Multiple and Portable ELISA
  • Competitive ELISA

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Immunology
  • Vaccine Development
  • Infectious Diseases
  • Cancer
  • Protein Quantitation
  • Others

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals and Diagnostic Centers
  • Pharmaceutical and Biotech Companies
  • Academic Research Centers
  • Clinical Laboratories
  • Others

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Enzyme-Linked Immunosorbent Assay (ELISA) Tests Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies enzyme-linked immunosorbent assay (ELISA) tests companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the enzyme-linked immunosorbent assay (ELISA) tests companies profiled in this report include-

  • Ortho Clinical Diagnostics
  • Thermo Fisher Scientific
  • Biomerieux
  • Sysmex Corporation
  • F. Hoffmann-La Roche
  • Danaher Corporation
  • Quidel Corporation
  • Bio-Rad Laboratories
  • Siemens Healthineers
  • Abbott Laboratories

Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Insights

Lucintel forecasts that multiple and portable ELISA is expected to witness highest growth over the forecast period due to portability and on-going technological advancements.

Within this market, hospitals and diagnostic centers will remain the largest segment due to the increasing prevalence of diseases, rising demand for personalized medicine, and growing government support for ELISA testing.

North America will remain the largest region over the forecast period due to surge in geriatric population, rising penetration of medical devices, and presence of well-advanced healthcare infrastructure in this region.

Features of the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market

Market Size Estimates: Enzyme-linked immunosorbent assay (ELISA) tests market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Enzyme-linked immunosorbent assay (ELISA) tests market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: Enzyme-linked immunosorbent assay (ELISA) tests market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, end uses, and regions for the enzyme-linked immunosorbent assay (ELISA) tests market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the enzyme-linked immunosorbent assay (ELISA) tests market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for enzyme-linked immunosorbent assay (ELISA) tests market?

Answer: The global enzyme-linked immunosorbent assay (ELISA) tests market is expected to grow with a CAGR of 7.5% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the enzyme-linked immunosorbent assay (ELISA) tests market?

Answer: The major drivers for this market are growing prevalance of infectious diseases, such as HIV, dengue, hepatitis, malaria, influenza, and others and growing geriatric population who are at a risk of developing several infections.

Q3. What are the major segments for enzyme-linked immunosorbent assay (ELISA) tests market?

Answer: The future of the enzyme-linked immunosorbent assay (ELISA) tests market looks promising with opportunities in the hospital and diagnostic center, pharmaceutical and biotech company, academic research center, and clinical laboratory markets.

Q4. Who are the key enzyme-linked immunosorbent assay (ELISA) tests market companies?

Answer: Some of the key enzyme-linked immunosorbent assay (ELISA) tests companies are as follows:

  • Ortho Clinical Diagnostics
  • Thermo Fisher Scientific
  • Biomerieux
  • Sysmex Corporation
  • F. Hoffmann-La Roche
  • Danaher Corporation
  • Quidel Corporation
  • Bio-Rad Laboratories
  • Siemens Healthineers
  • Abbott Laboratories

Q5. Which enzyme-linked immunosorbent assay (ELISA) tests market segment will be the largest in future?

Answer: Lucintel forecasts that multiple and portable ELISA is expected to witness highest growth over the forecast period due to portability and on-going technological advancements.

Q6. In enzyme-linked immunosorbent assay (ELISA) tests market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to surge in geriatric population, rising penetration of medical devices, and presence of well-advanced healthcare infrastructure in this region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the enzyme-linked immunosorbent assay (ELISA) tests market by type (sandwich ELISA, indirect ELISA, multiple and portable ELISA, and competitive ELISA), application (immunology, vaccine development, infectious diseases, cancer, protein quantitation, and others), end use (hospitals and diagnostic centers, pharmaceutical and biotech companies, academic research centers, clinical laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Type
    • 3.3.1: Sandwich ELISA
    • 3.3.2: Indirect ELISA
    • 3.3.3: Multiple and portable ELISA
    • 3.3.4: Competitive ELISA
  • 3.4: Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Application
    • 3.4.1: Immunology
    • 3.4.2: Vaccine Development
    • 3.4.3: Infectious diseases
    • 3.4.4: Cancer
    • 3.4.5: Protein quantitation
    • 3.4.6: Others
  • 3.5: Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by End Use
    • 3.5.1: Hospitals and Diagnostic Centers
    • 3.5.2: Pharmaceutical and Biotech Companies
    • 3.5.3: Academic Research Centers
    • 3.5.4: Clinical Laboratories
    • 3.5.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Region
  • 4.2: North American Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
    • 4.2.2: North American Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by End Use: Hospitals and Diagnostic Centers, Pharmaceutical and Biotech Companies, Academic Research Centers, Clinical Laboratories, and Others
  • 4.3: European Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
    • 4.3.1: European Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Type: Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA, and Competitive ELISA
    • 4.3.2: European Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by End Use: Hospitals and Diagnostic Centers, Pharmaceutical and Biotech Companies, Academic Research Centers, Clinical Laboratories, and Others
  • 4.4: APAC Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
    • 4.4.1: APAC Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Type: Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA, and Competitive ELISA
    • 4.4.2: APAC Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by End Use: Hospitals and Diagnostic Centers, Pharmaceutical and Biotech Companies, Academic Research Centers, Clinical Laboratories, and Others
  • 4.5: ROW Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
    • 4.5.1: ROW Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Type: Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA, and Competitive ELISA
    • 4.5.2: ROW Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by End Use: Hospitals and Diagnostic Centers, Pharmaceutical and Biotech Companies, Academic Research Centers, Clinical Laboratories, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Type
    • 6.1.2: Growth Opportunities for the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Application
    • 6.1.3: Growth Opportunities for the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by End Use
    • 6.1.4: Growth Opportunities for the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market by Region
  • 6.2: Emerging Trends in the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Enzyme-Linked Immunosorbent Assay (ELISA) Tests Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Ortho Clinical Diagnostics
  • 7.2: Thermo Fisher Scientific
  • 7.3: BioMerieux
  • 7.4: Sysmex Corporation
  • 7.5: F. Hoffmann-La Roche
  • 7.6: Danaher Corporation
  • 7.7: Quidel Corporation
  • 7.8: Bio-Rad Laboratories
  • 7.9: Siemens Healthineers
  • 7.10: Abbott Laboratories